🇺🇸 FDA
Patent

US 10456373

Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon

granted A61KA61K31/375A61K31/4415

Quick answer

US patent 10456373 (Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon) held by OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NORMOFARM” expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NORMOFARM”
Grant date
Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/375, A61K31/4415, A61K31/51, A61K45/06